AYTU · Aytu Biopharma, Inc · Documents
Market Cap
$22.75M
Shares
10.73M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-25 | 2026-06-23 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| 8-K | 2026-04-02 | 2026-03-31 | |
| 8-K | 2026-02-03 | — | |
| 10-Q | 2026-02-03 | 2025-12-31 | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2025-12-10 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| DEF 14A | 2025-10-24 | 2025-12-10 | |
| 8-K | 2025-09-23 | — | |
| 10-K | 2025-09-23 | 2025-06-30 | |
| 8-K | 2025-08-07 | 2025-08-05 | |
| 8-K | 2025-06-23 | 2025-06-20 | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 8-K | 2025-05-21 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-03-28 | 2025-05-21 | |
| 8-K | 2025-02-12 | — | |
| 10-Q | 2025-02-12 | 2024-12-31 | |
| 8-K | 2024-12-04 | 2024-12-03 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | 2024-11-11 | |
| 8-K | 2024-10-01 | — | |
| 8-K | 2024-09-26 | — | |
| 10-K | 2024-09-26 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-26 | — | |
| 8-K | 2024-06-18 | 2024-06-12 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| DEF 14A | 2024-05-10 | 2024-06-26 | |
| 10-Q | 2024-02-14 | 2023-12-31 | |
| 8-K | 2024-02-14 | — | |
| 8-K | 2023-11-17 | 2023-11-13 | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-11-14 | — | |
| 8-K | 2023-10-26 | 2023-10-25 | |
| 10-K | 2023-10-12 | 2023-06-30 | |
| 8-K | 2023-10-06 | 2023-10-03 | |
| 8-K | 2023-09-27 | — | |
| 8-K | 2023-08-15 | 2023-08-11 | |
| 8-K | 2023-07-31 | — | |
| 8-K | 2023-07-10 | — | |
| 8-K | 2023-06-12 | 2023-06-08 |
Showing 1–50 of 176 filings
Key facts
CIK
1385818
CUSIP
054754858
13F (30d)
24 filings
24 filers
Visit website
Investor relations